Correlation Between Johnson Johnson and Traws Pharma
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Traws Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Traws Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Traws Pharma, you can compare the effects of market volatilities on Johnson Johnson and Traws Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Traws Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Traws Pharma.
Diversification Opportunities for Johnson Johnson and Traws Pharma
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Johnson and Traws is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Traws Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Traws Pharma and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Traws Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Traws Pharma has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Traws Pharma go up and down completely randomly.
Pair Corralation between Johnson Johnson and Traws Pharma
Considering the 90-day investment horizon Johnson Johnson is expected to generate 0.14 times more return on investment than Traws Pharma. However, Johnson Johnson is 7.08 times less risky than Traws Pharma. It trades about -0.14 of its potential returns per unit of risk. Traws Pharma is currently generating about -0.05 per unit of risk. If you would invest 15,886 in Johnson Johnson on September 2, 2024 and sell it today you would lose (385.00) from holding Johnson Johnson or give up 2.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Johnson Johnson vs. Traws Pharma
Performance |
| Timeline |
| Johnson Johnson |
| Traws Pharma |
Johnson Johnson and Traws Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Johnson Johnson and Traws Pharma
The main advantage of trading using opposite Johnson Johnson and Traws Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Traws Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Traws Pharma will offset losses from the drop in Traws Pharma's long position.| Johnson Johnson vs. Crinetics Pharmaceuticals | Johnson Johnson vs. Enanta Pharmaceuticals | Johnson Johnson vs. Amicus Therapeutics | Johnson Johnson vs. Connect Biopharma Holdings |
| Traws Pharma vs. MI Homes | Traws Pharma vs. Treasury Wine Estates | Traws Pharma vs. SNDL Inc | Traws Pharma vs. Smith Douglas Homes |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |